← Open Payments lookup

RIMA LINVILLE: Open Payments

NPI 1265674881 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$893 in 32 payments from 14 companies in 2025. Trend: 2023 $567 · 2024 $1,100 · 2025 $893

Food & beverage: $893
CompanyPaymentsAmount
ABBVIE INC.4$217
GlaxoSmithKline, LLC.8$171
Merck Sharp & Dohme LLC4$120
AstraZeneca Pharmaceuticals LP2$57
Novartis Pharmaceuticals Corporation2$57
PFIZER INC.2$53
EMD Serono, Inc.2$48
Exelixis Inc.2$38
Daiichi Sankyo Inc.1$30
Apellis Pharmaceuticals, Inc.1$28

Products named: ELAHERE, JEMPERLI, KEYTRUDA, ZEJULA, CABOMETYX, Fabhalta, CALQUENCE, LYNPARZA.

Industry payments across TX — which companies pay providers there.